Pitch 1 ehv heart failure clinic

1. 13/11/2014
1
azM
U
M
azM
Mixed-methods research on care processes in heart failure
U
 Communication as major drawback resulting in insufficient treatment
M
 Also vividly discussed during dissemination events
 Knowledge of patients rather poor (despite HF nurses)
 Level of communication with patients inadequate
 Quite different priorities in therapy between GP’s and specialists
Transnational HF network
Development of patient-centred telemedicine device
 Patient-education and -monitoring

2. 13/11/2014
2
azM
U
M
 Estimate of app. 15 million
patients in Europe
 One of the most costly diseases
 App. 2% of health care budget
 One of the most malignant diseases
 Most common reason for hospital-ization
in pts aged >65years
 Usually accompanied with multiple
co-morbidities
 40% have ≥5 co-morbidities
20%
18%
16%
14%
12%
10%
8%
6%
4%
2%
0%
40 50 60 70 80 90
Age
azM
U
M
Clinical input
Standard regimen according to
guidelines
NYHA class
LVEF, HF‐etiology
Lab results, ECG
Signs & Symptoms
Age, Co‐morbidites,
Side‐effects

3. 13/11/2014
3
azM
Symptoms, aetiology etc.
Co-morbidities
U
HF-related
M
Patient preferences
Patient knowledge
Patient capabilities
Biomarkers (e.g. NT-proBNP,
sST2)
miRNA
Clinical input “Sensor” input
Patient input
Enhanced treatment decision
Drug/Dose regimen A Drug/Dose regimen B Drug/Dose regimen C
Optimising individual treatment
Targeted drug use & minimizing side effects
(decreased medication for same benefit / increased medication for increased benefit)
related
Tele-medicine sensors
(e.g. impedance, BP)
Development of patient-centred, decision support system,
which is based on tele-medicine device in order to
 Improve patient knowledge
 Transfer large parts of treatment to patients’ home, run by the patients
 Individualize care of patients
 Improve communication between all important stakeholders (i.e.
azM
U
M
patient, GP, cardiologist, other specialists if applicable, heart failure
nurse if applicable, paramedics as applicable)
 Improve outcome of patients
 Reduce costs

4. 13/11/2014
4
Which parts are crucial for further development and
implementation?
What innovation is required?
azM
Impossible to address all aspects in one project
U
 Focus on aims that realistically can be achieved
 Product innovation
 Service innovation
 Process innovation
M
azM
Improved communication between all stakeholders of care
Improved care processes with more patient’s self-management
ICT infrastructure for coordinated and integrated care
Improvement in care of chronic diseases
U
 GP’s, specialists, paramedicals, and importantly patients
 Tele-health central (with different focus than at present)
 Important business opportunities
 Collaboration academic institutes and industrial partners
 Tackling the needs of the growing elderly population
M

5. 13/11/2014
5
Influence of different health-care systems unknown, but
probably much underestimated
Implementation in different countries not uniform
Business models may vary in different countries
azM
Taking advantage of knowledge in different countries
U
 Partners with specific expertise
M